Clinical Trial Update: Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating strategies to prevent graft-versus-host disease in patients undergoing bone marrow transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Lymphoma

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Graft Versus Host Disease, Leukemia | Phase 3 | Status: COMPLETED